ArticleFrontiers in immunology2026
Integrated multi-omics and machine learning identify core mechanobiology-associated immune genes in pulmonary arterial hypertension.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary arterial hypertension (PAH) involves vascular remodeling and altered mechanical signaling. The immune-associated transcriptomic changes accompanying this environment remain incompletely characterized. Methods: We integrated bulk lung (GSE15197), PBMC (GSE33463), and single-cell RNA-seq (GSE169471) data using a curated set of 2, 537 mechanical-related genes. WGCNA, LASSO, random forest, and single-cell localization supported candidate prioritization. The four-gene panel was examined in a monocrotaline-induced PH rat model and PBMCs from 10 IPAH patients and 10 controls. Results: PAH transcriptomes showed enrichment of stress-fiber, actomyosin, ECM, and immune-related programs. CD83, CD86, IL6, and TLR7 were prioritized, with compartment-dependent expression patterns. Single-cell data localized CD83/CD86 to myeloid/APC compartments and IL6 to endothelial/fibroblast populations; TLR7 was sparsely detected. In MCT-treated rat lungs, CD86 and TLR7 proteins increased, whereas CD83 and IL-6 decreased. Clinical PBMCs showed corresponding expression directions, and each gene had an AUC >0.7. The exploratory four-gene disease-state score achieved an internal cross-validated AUC of 0.765. Conclusions: The four candidates provide a cellular and molecular context for investigating immune-stromal interactions in PAH, including responses to noninfectious vascular injury. The panel showed moderate internal discrimination. These findings support further clinical and functional investigation but do not establish direct mechanotransduction targets or a causal pathway linking mechanical stress to vascular inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.